Cargando…

Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes

BACKGROUND: Patients with type 2 diabetes (T2D) treated with glucagon-like peptide-1 receptor agonists may experience reductions in weight and blood pressure. The primary objective of the current study was to determine the weight-dependent and weight-independent effects of ~ 6 months treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferdinand, Keith C., Dunn, Julia, Nicolay, Claudia, Sam, Flora, Blue, Emily K., Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999488/ https://www.ncbi.nlm.nih.gov/pubmed/36894938 http://dx.doi.org/10.1186/s12933-023-01775-x

Ejemplares similares

The effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
por: Ruda, Alexandru Ioan, et al.
Publicado: (2023)

Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008)

Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once‐weekly dulaglutide treatment
por: Umpierrez, G. E., et al.
Publicado: (2016)

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11
por: Bonora, Enzo, et al.
Publicado: (2021)

Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events
por: Ferdinand, Keith C., et al.
Publicado: (2016)

Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme
por: Dungan, K. M., et al.
Publicado: (2016)

Advances in the treatment of type 2 diabetes: impact of dulaglutide
por: Thompson, Angela M, et al.
Publicado: (2016)

Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD‐11 study
por: Cox, David A., et al.
Publicado: (2022)

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2022)

Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents
por: Gentilella, Raffaella, et al.
Publicado: (2019)

Exploring Responses to Body Weight Criticism: Defensive Avoidance When Weight Is Seen as Controllable
por: Täuber, Susanne, et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes
por: Alduraibi, Rabia Khalid, et al.
Publicado: (2023)

THE INTRARENAL PRESSURE : ITS RELATION TO AGE, WEIGHT, BLOOD PRESSURE, AND SEX
por: Montgomery, A. V., et al.
Publicado: (1950)

Lorcaserin and metabolic disease: weight‐loss dependent and independent effects
por: Bays, H., et al.
Publicado: (2018)

The effects of insulin therapy on maternal blood pressure and weight in women with gestational diabetes mellitus
por: Sun, Tiange, et al.
Publicado: (2021)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States
por: Wilkinson, Lars, et al.
Publicado: (2018)

Effects of Restricted Fructose Access on Body Weight and Blood Pressure Circadian Rhythms
por: Senador, Danielle, et al.
Publicado: (2012)

Factors modifying the association between birth weight and blood pressure
por: Schreuder, Michiel F.
Publicado: (2010)

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
por: Edwards, Krystal L, et al.
Publicado: (2015)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide
por: Ghosh, Aneesh
Publicado: (2021)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Mode of administration of dulaglutide: implications for treatment adherence
por: Amblee, Ambika
Publicado: (2016)

Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2021)

Exacerbation of atrial fibrillation related to dulaglutide use
por: Lee, Jayden, et al.
Publicado: (2021)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

Walnut consumption in a weight reduction intervention: effects on body weight, biological measures, blood pressure and satiety
por: Rock, Cheryl L., et al.
Publicado: (2017)

Direct comparisons of commercial weight-loss programs on weight, waist circumference, and blood pressure: a systematic review
por: Vakil, Rachit M., et al.
Publicado: (2016)

Elevated blood pressure in youth in pediatric weight management programs in the Pediatric Obesity Weight Evaluation Registry (POWER)
por: Binns, Helen J., et al.
Publicado: (2022)

Excess Weight, Anthropometric Variables and Blood Pressure in Schoolchildren aged 10 to 18 years
por: Schommer, Vânia Ames, et al.
Publicado: (2014)

Achieving the composite end‐point of glycated hemoglobin <7.0% without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis
por: Xiao, Xinhua, et al.
Publicado: (2020)

Estimating Blood Pressure in Children and Adolescents: Should Body Weight be Included?
por: Schwandt, Peter
Publicado: (2013)

High-Normal Arterial Blood Pressure in Children With Excess Body Weight
por: Kolpa, Malgorzata, et al.
Publicado: (2016)

Gestational weight gain, nutritional status and blood pressure in pregnant women
por: Campos, Chiara Alzineth Silva, et al.
Publicado: (2019)

Higher blood pressure in normal weight women with PCOS compared to controls
por: Mellembakken, Jan Roar, et al.
Publicado: (2021)

Group Medical Visits for Addressing Weight and Blood Pressure in an Underserved Population
por: Algotar, Amit, et al.
Publicado: (2022)

Birth Weight, Postnatal Weight Gain, and Childhood Adiposity in Relation to Lipid Profile and Blood Pressure During Early Adolescence
por: Hulst, Andraea Van, et al.
Publicado: (2017)

Number of Educational Sessions Attended Was Not Associated With Weight Loss or Blood Pressure Changes in African Americans Enrolled in Weight Matters
por: Blakeney, Rochelle, et al.
Publicado: (2022)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2s59idh89icl0nlkhhgj8n969d